World's Best Scientists 2026 revealed!
Matthew G. Vander Heiden

Matthew G. Vander Heiden

D-Index & Metrics

Biology and Biochemistry

D-Index
123
Citations
101419
World Ranking
541
National Ranking
342

Overview

Matthew G. Vander Heiden is a researcher affiliated with MIT in the United States. Their work primarily intersects the fields of Biochemistry, Genetics and Molecular Biology, and Medicine, with a substantial focus on Molecular Biology, Cancer Research, Oncology, Pulmonary and Respiratory Medicine, and Physiology as subfields of study.

The main topics covered in their research include:

  • Cancer, Hypoxia, and Metabolism
  • Epigenetics and DNA Methylation
  • Mitochondrial Function and Pathology
  • RNA modifications and cancer
  • Metabolomics and Mass Spectrometry Studies
  • Cancer, Lipids, and Metabolism
  • Metabolism, Diabetes, and Cancer

Recent notable publications by Matthew G. Vander Heiden include:

  • Cell-programmed nutrient partitioning in the tumour microenvironment, 2021, Nature
  • Metabolomics in cancer research and emerging applications in clinical oncology, 2021, CA A Cancer Journal for Clinicians
  • Increased demand for NAD+ relative to ATP drives aerobic glycolysis, 2020, Molecular Cell
  • Emerging Roles for Branched-Chain Amino Acid Metabolism in Cancer, 2020, Cancer Cell
  • A metastasis map of human cancer cell lines, 2020, Nature

The scientist has frequently published in the following venues:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Cancer Research
  • Nature Communications
  • Nature
  • Trends in Biochemical Sciences

Frequent co-authors collaborating with Matthew G. Vander Heiden consist of:

  • Keene L. Abbott
  • Ahmed Ali
  • Caroline A. Lewis
  • T. Brian
  • Daniel R. Schmidt

Best Publications

  • Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation

    Matthew G. Vander Heiden;Lewis C. Cantley;Craig B. Thompson

  • Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018

    Lorenzo Galluzzi;Ilio Vitale;Stuart A. Aaronson;John M. Abrams

  • Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

    Lenny Dang;David W. White;Stefan Gross;Bryson D. Bennett

  • The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth

    Heather R. Christofk;Matthew G. Vander Heiden;Marian H. Harris;Arvind Ramanathan

  • Aerobic Glycolysis: Meeting the Metabolic Requirements of Cell Proliferation

    Sophia Y. Lunt;Matthew G. Vander Heiden

  • Activation of a Metabolic Gene Regulatory Network Downstream of mTOR Complex 1

    Katrin Düvel;Jessica L. Yecies;Suchithra Menon;Pichai Raman

  • Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia

    Christian M. Metallo;Paulo A. Gameiro;Eric L. Bell;Katherine R. Mattaini

  • Understanding the Intersections between Metabolism and Cancer Biology

    Matthew G. Vander Heiden;Matthew G. Vander Heiden;Ralph J. DeBerardinis

  • Targeting cancer metabolism: a therapeutic window opens

    Matthew G. Vander Heiden;Matthew G. Vander Heiden

  • Bcl-xL Regulates the Membrane Potential and Volume Homeostasis of Mitochondria

    Matthew G. Vander Heiden;Navdeep S. Chandel;Edward K. Williamson;Paul T. Schumacker

  • Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells

    Cosimo Commisso;Shawn M. Davidson;Rengin G. Soydaner-Azeloglu;Seth J. Parker

  • Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis

    Jason W. Locasale;Alexandra R. Grassian;Tamar Melman;Costas A. Lyssiotis

  • Inhibition of Pyruvate Kinase M2 by Reactive Oxygen Species Contributes to Cellular Antioxidant Responses

    Dimitrios Anastasiou;Dimitrios Anastasiou;George Poulogiannis;George Poulogiannis;John M. Asara;John M. Asara;Matthew B. Boxer

  • Pyruvate kinase M2 is a phosphotyrosine-binding protein

    Heather R. Christofk;Matthew G. Vander Heiden;Ning Wu;John M. Asara;John M. Asara

  • Pyruvate Kinase M2 Regulates Hif-1α Activity and IL-1β Induction and Is a Critical Determinant of the Warburg Effect in LPS-Activated Macrophages

    Eva M. Palsson-McDermott;Anne M. Curtis;Gautam Goel;Gautam Goel;Mario A.R. Lauterbach

  • Supporting Aspartate Biosynthesis Is an Essential Function of Respiration in Proliferating Cells

    Lucas B. Sullivan;Dan Y. Gui;Aaron M. Hosios;Lauren N. Bush

  • Bcl-2 proteins: regulators of apoptosis or of mitochondrial homeostasis?

    Vander Heiden Mg;Thompson Cb

  • Tyrosine Phosphorylation Inhibits PKM2 to Promote the Warburg Effect and Tumor Growth

    Taro Hitosugi;Sumin Kang;Matthew G. Vander Heiden;Tae Wook Chung

  • Inhibition of Pyruvate Kinase M2 by Reactive Oxygen Species Contributes to Cellular Antioxidant Responses

    Matthew G. Vander Heiden;Dimitrios Anastasiou;George Poulogiannis;John M. Asara

  • Amplification of phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis

    J. Locasale;J. Locasale;Alexandra Grassian;Rameen Beroukhim;Matthew Langer Meyerson

Frequent Co-Authors

Lewis C. Cantley
Lewis C. Cantley Harvard University
Clary B. Clish
Clary B. Clish Broad Institute
John M. Asara
John M. Asara Beth Israel Deaconess Medical Center
Craig B. Thompson
Craig B. Thompson Memorial Sloan Kettering Cancer Center
Jason W. Locasale
Jason W. Locasale Duke University
Craig J. Thomas
Craig J. Thomas National Institutes of Health
Christian M. Metallo
Christian M. Metallo University of California, San Diego
Lorelei A. Mucci
Lorelei A. Mucci Harvard University
Roderick T. Bronson
Roderick T. Bronson Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Matthew G. Vander Heiden

Trending Scientists